Abstract:Cellular growth, function, and protection require proper iron management, and ferritin plays a crucial role as the major iron sequestration and storage protein. Ferritin is a 24 subunit spherical shell protein composed of both light (FTL) and heavy chain (FTH1) subunits, possessing complimentary iron-handling functions and forming three-fold and four-fold pores. Iron uptake through the three-fold pores is well-defined, but the unloading process somewhat less and generally focuses on lysosomal ferritin degradation although it may have an additional, energetically efficient pore mechanism. Hereditary Ferritinopathy (HF) or neuroferritinopathy is an autosomal dominant neurodegenerative disease caused by mutations in the FTL C-terminal sequence, which in turn cause disorder and unraveling at the four-fold pores allowing iron leakage and enhanced formation of toxic, improperly coordinated iron (ICI). Histopathologically, HF is characterized by iron deposition and formation of ferritin inclusion bodies (IBs) as the cells overexpress ferritin in an attempt to address iron accumulation while lacking the ability to clear ferritin and its aggregates. Overexpression and IB formation tax cells materially and energetically, i.e., their synthesis and disposal systems, and may hinder cellular transport and other spatially dependent functions. ICI causes cellular damage to proteins and lipids through reactive oxygen species (ROS) formation because of high levels of brain oxygen, reductants and metabolism, taxing cellular repair. Iron can cause protein aggregation both indirectly by ROS-induced protein modification and destabilization, and directly as with mutant ferritin through C-terminal bridging. Iron release and ferritin degradation are also linked to cellular misfunction through ferritinophagy, which can release sufficient iron to initiate the unique programmed cell death process ferroptosis causing ROS formation and lipid peroxidation. But IB buildup suggests suppressed ferritinophagy, with elevated iron from four-fold pore leakage together with ROS damage and stress leading to a long-term ferroptotic-like state in HF. Several of these processes have parallels in cell line and mouse models. This review addresses the roles of ferritin structure and function within the above-mentioned framework, as they relate to HF and associated disorders characterized by abnormal iron accumulation, protein aggregation, oxidative damage, and the resulting contributions to cumulative cellular stress and death.

Ferritin for the clinician

New Perspectives on Circulating Ferritin: Its Role in Health and Disease

Emerging and Dynamic Biomedical Uses of Ferritin

Case studies: iron

Chemistry and biology of ferritin

Ferritin, cellular iron storage and regulation

Structure, Function and Clinical Significance of Transferrin Receptors

The significance of ferritin as one of the markers of inflammation

Investigation and management of a raised serum ferritin

Interpretation of Ferritin Concentrations in the Dermatology Clinic

Ferritin: a novel mechanism for delivery of iron to the brain and other organs

Ferritin and ferritin isoforms I: Structure–function relationships, synthesis, degradation and secretion

Iron, Ferritin, Hereditary Ferritinopathy, and Neurodegeneration

IRON, FERRITIN, AND NUTRITION

Ferritin, inflammation, and iron deficiency in acute heart failure: evidence from the EDIFICA cohort

Hyperferritinemia: Important Differentials for the Rheumatologists

Ferritin – a multifaceted protein scaffold for biotherapeutics

Ferritin Hinders Ferroptosis in Non-Tumorous Diseases: Regulatory Mechanisms and Potential Consequences

Ferritin: Significance in viral infections

Ferritin is secreted via two distinct non-classical vesicular pathways Ferritin Trafficking and Secretion